It adds that the loss this year is attributed to its slower-than-expected ramp-up in its business operations, that may result in an impairment to its assets.
Singapore Institute of Advanced Medicine Holdings (SAM Holdings) is expected to report a “significant” net loss after tax for the FY2024 ended June 30, marking another year of net losses. The group reported a net loss after tax in FY2023.
“As described in the risk factors outlined in the group’s offer document, the group incurred loss after tax in FY2023 following the continued development and expansion of the business operations and there is a risk that the group may continue reporting losses,” says the company in its July 31 profit guidance statement.
